Risk of Drug-Drug Interactions in Patients With HIV and Cancer
As many as 1 in 4 patients receiving treatment for cancer and HIV may be at risk of experiencing drug-drug interactions, according to researchers.
As many as 1 in 4 patients receiving treatment for cancer and HIV may be at risk of experiencing drug-drug interactions, according to researchers.
A team of researchers evaluated the efficacy of a chemotherapy regimen commonly used to treat advanced cancer in a group of patients living with HIV.
This fact sheet examines the impact of the human immunodeficiency virus (HIV) on cancer risk.
Researchers investigated the efficacy and safety of CHOP-like therapy for treatment-naïve patients with simultaneous diagnoses of NHL and HIV-positive.
The stigma patients with HIV face has been shown to negatively effect their experiences while undergoing cancer care.
Significantly higher rates of relapse or death for HIV-infected men with prostate cancer, women with breast cancer.
Antiretroviral therapy has led to a dramatic reduction in incidence of AIDS-related Kaposi sarcoma; however, changes in the disease may lead to a resurgence in its risk for people with HIV infection.
Do you have any resources that give specific guidelines or even anecdotal sources on how to adjust etoposide dose in a patient taking Prezcobix?
Canadian investigators conducted a national observational study in which women and girls living with HIV underwent HPV vaccination.
Populating a microsimulation of model of HIV disease, researchers investigated the the likelihood of lung cancer-related morbidity and mortality among patients with HIV who smoke, based on smoking intensity.